Devices › Device types
FDA product code JDH · class 3 · Orthopedic
Prosthesis, hip, hemi-, trunnion-bearing, femoral, metal/polyacetal: medical device reports filed with FDA
2,621 reports carry this product code, 1994–2025; 18 brands with a page.
- 2,621
- reports with this product code
- 0% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 2 in the 12 months before
- 3.4%
- classified as malfunction
- 62.3% across all reports
- 0.2%
- classified as death, as reported
- 0.9% across all reports
Product code JDH is FDA's classification for "Prosthesis, hip, hemi-, trunnion-bearing, femoral, metal/polyacetal" (orthopedic panel), a class 3 device. 2,621 medical device reports carry this product code, 0% of the MAUDE database, from February 1994 to July 2025.
0 reports arrived in the 12 months to August 2026, against 2 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (96%), malfunction (3.4%) and death (0.2%). 18 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Hip Implant | 316 | 0 | 1.1% | 0.3% |
| Reflection | 171 | 0 | 0% | 3.6% |
| Plus | 77 | 0 | 0.4% | 0% |
| Synergy | 54 | 84 | 3.5% | 63.3% |
| Echelon | 44 | 584 | 3.2% | 72.8% |
| R3 | 42 | 0 | 0.2% | 0.5% |
| Unkn Orthopaedic Reconstruction Dev | 34 | 17 | 0.4% | 5% |
| Unkn Birmingham Hip Resurfacing Bhr Cup Unkn Type | 18 | 0 | 0.9% | 0% |
| Femoral Head | 9 | 11 | 0% | 2.3% |
| Unknown Hip Implant | 5 | 9 | 0.6% | 3.4% |
| Knee Implant | 2 | 0 | 0% | 1.6% |
| Accord Dual Ended Hex Driver | 1 | 0 | 0% | 92.6% |
| Femoral Head Impactor | 1 | 9 | 0% | 91.9% |
| Marathon | 1 | 66 | 5.9% | 54.9% |
| Mi Z Handle Acet Reamer | 1 | 22 | 0% | 87.3% |
| R3 Straight Shell Impactor | 1 | 21 | 0% | 91.2% |
| UNK Cup | 1 | 78 | 0% | 4.6% |
| Unknown Femoral Head | 1 | 8 | 1.4% | 0.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Smith & Nephew | 1,477 | 56.4% |
| Smith & Nephew Orthopaedics | 228 | 8.7% |
| Howmedica | 3 | 0.1% |
| Zimmer | 2 | 0.1% |
| Biomet France R L | 1 | 0% |
| Depuy Intl - 8010379 | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Insufficient device problem information | 873 | 33.3% |
| Device dislodged or dislocated | 342 | 13% |
| Fracturea broken bone | 198 | 7.6% |
| Device slipped | 141 | 5.4% |
| Breakthe device broke | 130 | 5% |
| Loose or intermittent connection | 73 | 2.8% |
| Naturally worn | 69 | 2.6% |
| Loosening of implant not related to bone-ingrowth | 50 | 1.9% |
| Explanted | 47 | 1.8% |
| Device operates differently than expectedthe device behaved unexpectedly | 33 | 1.3% |
| Migration or expulsion of device | 23 | 0.9% |
| Unintended movement | 22 | 0.8% |
| Biocompatibility | 20 | 0.8% |
| Unstable | 20 | 0.8% |
| Replace | 17 | 0.6% |
| Dislocated | 16 | 0.6% |
| Corrodedthe device corroded | 15 | 0.6% |
| Positioning problem | 15 | 0.6% |
| Difficult to insertthe device was hard to insert | 14 | 0.5% |
| Detachment of device component | 11 | 0.4% |
Questions about prosthesis, hip, hemi-, trunnion-bearing, femoral, metal/polyacetal reports
What is product code JDH?
FDA's classification code for "Prosthesis, hip, hemi-, trunnion-bearing, femoral, metal/polyacetal", class 3, reviewed by the orthopedic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,621 reports through August 2026, 0 of them in the latest 12 months.
Which brands appear most often?
Hip Implant (316), Reflection (171), Plus (77), Synergy (54) and Echelon (44). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.